4.62 USD
↗ 0.01 (0.24%)PRE MARKET (AS OF 04:01 AM EDT)
Aquestive Therapeutics, Inc. Common Stock
AQSTNASDAQ • USD
Market: OPEN
Shares of Aquestive Therapeutics, Inc. Common Stock (AQST) are trading at $4.62. Technicals currently rate "Neutral" while our fundamental analysis reads "Sell". Notable factors include a concerning Altman Z-Score in the distress zone, exceptional Return on Equity (138.2%) and a bullish Golden Cross on the moving averages. Valuation-wise, the stock is priced at a premium — multiples like P/E and EV/EBITDA sit above sector averages.
Technical & fundamental data as of Oct 6, 2026.
Open?$4.62
High?$4.62
Low?$4.62
Prev. Close?$4.61
Volume?N/A
Avg. Volume?2.3M
Bid / Ask
Bid?$4.59 × 200
Ask?$4.61 × 200
Spread?$0.02
Midpoint?$4.60
Valuation & Ratios
Market Cap?578.6M
Shares Out?125.5M
Float?107.7M
Float %?85.8%
P/E Ratio?N/A
P/B Ratio?-10.23
EPS?-$0.62
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Aquestive Therapeutics Inc is a specialty pharmaceutical company engaged in developing and commercializing differentiated products to meet medical needs. Its later-stage product pipeline focuses on the treatment of diseases of the Central Nervous System (CNS), and an earlier-stage pipeline for the treatment of severe allergic reactions, including anaphylaxis. Its commercial product portfolio includes Suboxone, Emylif, Ondif, and Sympazan. The product pipeline includes Libervant Buccal Film, AQST-108. The majority of its revenue comes from the United States.
Employees
147
Market Cap
573.6M
Industry
PHARMACEUTICAL PREPARATIONS
Website
Listed
2018-07-25
Address
30 TECHNOLOGY DRIVE
WARREN, NJ 07059
Phone: 908-941-1900
WARREN, NJ 07059
Phone: 908-941-1900
Technical OutlookNeutral
Strong SellNeutralStrong Buy
Long-Term (Tide)?▼ Bearish(-1/3)
Medium-Term (Wave)?– Neutral(0/3)
Short-Term (Ripple)?▲ Bullish(+2/3)
MA Alignment?Mixed
Full Technical Analysis →Fundamental OutlookSell
Strong SellNeutralStrong Buy
F-Score?40
Z-Score?0
Momentum?73
Short Sent.?25
Piotroski F-Score?4/9Mixed
Altman Z-Score?-3.28Distress
Confidence?54%Low
Short InterestSqueeze Risk
Short % of Float?25.23%Squeeze Risk
Short Interest?27.2M
Days to Cover?11.8
Free Float107.7M
Avg Daily Volume2.3M
Settlement Date2026-09-15
Financial Health
Current Ratio?7.19Strong
Quick Ratio?6.74Strong
Cash Ratio?5.98Strong
Debt/Equity?-0.90Low
ValuationFAIRLY VALUEDvs 1 peers + S&P 500
Score67/100
P/E?N/A▾
P/B?-10.23CHEAP▾
S&P97
P/S?10.70HIGH▾
Peers100
S&P7
P/FCF?N/A▾
EV/EBITDA?-9.6CHEAP▾
S&P97
EV/Sales?9.81HIGH▾
Peers100
S&P11
Returns & Efficiency
ROE?138.2%STRONG▾
Peers50
S&P97
ROA?-59.2%WEAK▾
S&P3
Cash Flow & Enterprise
FCF?$-45949000
Enterprise Value?$530.8M
Fundamentals ratios updated end of day